Efficacy and Safety of Silodosin on Voiding Dysfunction Associated With Neurogenic Bladder

NCT01228370 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

95

Enrollment

INDUSTRY

Sponsor class

Conditions

Neurogenic Bladder
Voiding Dysfunction

Interventions

DRUG: silodosin

Sponsor

JW Pharmaceutical